Late Anastomotic Dehiscence during Bevacizumab Therapy for Patients with Colorectal Cancer

Clinical Oncology

Volumn 23, Issue 7, 2011, Pages 497-498

  Garant, A ^a   Des Groseilliers, S ^b   Martin, L ^b   Ferland, E ^b   Vuong, T ^c  

^a UNIVERSITÉ LAVAL   (Canada)

^b Centre Hospitalier de Pierre Boucher   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADULT; ANASTOMOSIS DEHISCENCE; CANCER STAGING; CANCER SURGERY; CASE REPORT; CHEMORADIOTHERAPY; COLORECTAL CARCINOMA; DEATH; HUMAN; LETTER; LIVER METASTASIS; LUNG METASTASIS; MULTIPLE CYCLE TREATMENT; NECROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFORATION; PRIORITY JOURNAL; SIDE EFFECT;

ADENOCARCINOMA; ANASTOMOTIC LEAK; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; COLORECTAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; NEOPLASM GRADING; ORGANOPLATINUM COMPOUNDS; SURGICAL WOUND DEHISCENCE;

EID: 79960900223     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2011.03.009     Document Type: Letter

References (5)

1. Van Cutsem E., et al. Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study. Ann Oncol 2009, 20(11):1842-1847.
2. Auer R.A., et al. Rectal complications during bevacizumab treatment for metastatic rectal cancer are increased in the setting of prior radiation. American Society of Clinical Oncology - Gastrointestinal Cancers Symposium 2008.
3. Tamiya A., et al. Safety of bevacizumab treatment in combination with standard chemotherapy for metastatic colorectal cancer: a retrospective review of 65 Japanese patients. Int J Clin Oncol 2009, 14(6):513-517.
4. Saif M.W., Mehra R. Incidence and management of bevacizumab-related toxicities in colorectal cancer. Expert Opin Drug Saf 2006, 5(4):553-566.
5. Deshaies I., et al. Antiangiogenic agents and late anastomotic complications. J Surg Oncol 2010, 101(2):180-183.